GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.
from RSS Feeds : RSS Feed - NDTV Gadgets360.com http://bit.ly/2DTO11A
Tuesday, 7 May 2019
Home »
RSS Feeds : RSS Feed - NDTV Gadgets360.com
» Alphabet's GV Leads Funding in Gene Editing Company Verve Therapeutics






0 comments:
Post a Comment